Pedro Cardoso

6PUBLICATIONS

16CO-AUTHORS

Labour, migration and developmentPharmacogenomicsBehavioural epidemiologyMolecular targetsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 04, 2026

Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024.

|May 16, 2025

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study.

Pedro Cardoso, Katie G Young, Rhian Hopkins

|Aug 27, 2024

Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.

Pedro Cardoso, Katie G Young, Andrew T Hattersley

|Jun 05, 2024

Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.

Laura M Güdemann, Katie G Young, Nicholas J M Thomas

|Jun 04, 2024

Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.

Pedro Cardoso, Timothy J McDonald, Kashyap A Patel

|Feb 22, 2024

Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

Pedro Cardoso, Katie G Young, Anand T N Nair

Pageof 1

Frequent Collaborators

Beverley M Shields

Andrew T Hattersley

John M Dennis

Rhian Hopkins

Angus G Jones

Ewan R Pearson

Katie G Young

Laura M Güdemann

Trevelyan J McKinley

Nicholas J M Thomas

Frequent Collaborators

Beverley M Shields

Andrew T Hattersley

John M Dennis

Rhian Hopkins